CA2541869C - Compositions et procedes servant au ciblage de la destruction vasculaire - Google Patents

Compositions et procedes servant au ciblage de la destruction vasculaire Download PDF

Info

Publication number
CA2541869C
CA2541869C CA2541869A CA2541869A CA2541869C CA 2541869 C CA2541869 C CA 2541869C CA 2541869 A CA2541869 A CA 2541869A CA 2541869 A CA2541869 A CA 2541869A CA 2541869 C CA2541869 C CA 2541869C
Authority
CA
Canada
Prior art keywords
cytotoxic
prodrug
cells
phosphate
vascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2541869A
Other languages
English (en)
Other versions
CA2541869A1 (fr
Inventor
David Sherris
Ronald W. Pero
George R. Pettit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arizona State University ASU
Original Assignee
Arizona State University ASU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arizona State University ASU filed Critical Arizona State University ASU
Priority claimed from CA2358925A external-priority patent/CA2358925C/fr
Publication of CA2541869A1 publication Critical patent/CA2541869A1/fr
Application granted granted Critical
Publication of CA2541869C publication Critical patent/CA2541869C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2541869A 1999-02-18 2000-02-16 Compositions et procedes servant au ciblage de la destruction vasculaire Expired - Lifetime CA2541869C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12047899P 1999-02-18 1999-02-18
US60/120,478 1999-02-18
CA2358925A CA2358925C (fr) 1999-02-18 2000-02-16 Compositions et procedes servant au ciblage de la destruction vasculaire

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2358925A Division CA2358925C (fr) 1999-02-18 2000-02-16 Compositions et procedes servant au ciblage de la destruction vasculaire

Publications (2)

Publication Number Publication Date
CA2541869A1 CA2541869A1 (fr) 2000-08-24
CA2541869C true CA2541869C (fr) 2013-06-11

Family

ID=32094420

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002455956A Abandoned CA2455956A1 (fr) 1999-02-18 2000-02-16 Compositions et procedes servant au ciblage de la destruction vasculaire
CA2541869A Expired - Lifetime CA2541869C (fr) 1999-02-18 2000-02-16 Compositions et procedes servant au ciblage de la destruction vasculaire

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA002455956A Abandoned CA2455956A1 (fr) 1999-02-18 2000-02-16 Compositions et procedes servant au ciblage de la destruction vasculaire

Country Status (1)

Country Link
CA (2) CA2455956A1 (fr)

Also Published As

Publication number Publication date
CA2455956A1 (fr) 2000-08-24
CA2541869A1 (fr) 2000-08-24

Similar Documents

Publication Publication Date Title
CA2358925C (fr) Compositions et procedes servant au ciblage de la destruction vasculaire
JP2002537262A5 (fr)
Xing et al. The relationship of redox with hallmarks of cancer: the importance of homeostasis and context
Ardura et al. Targeting macrophages: friends or foes in disease?
Freeman et al. The source of choline for acetylcholine synthesis in brain
Giraud et al. Oxazaphosphorines: new therapeutic strategies for an old class of drugs
Jia et al. Neuroprotective effects of the anti-cancer drug lapatinib against epileptic seizures via suppressing glutathione peroxidase 4-dependent ferroptosis
Farooqui et al. Inhibitors of intracellular phospholipase A2 activity: their neurochemical effects and therapeutical importance for neurological disorders
Bernardi et al. Mitochondrial energy dissipation by fatty acids: Mechanisms and implications for cell death
KR101113436B1 (ko) 약학적 제제의 제조를 위한 화학식 ａ?ｒ?ｘ의 화합물
Gradinaru et al. Procaine–the controversial geroprotector candidate: new insights regarding its molecular and cellular effects
JP5568484B2 (ja) Ｌｐａ受容体アゴニストおよびアンタゴニスト
MXPA01008245A (es) Combinaciones para el tratamiento de las enfermedades que comprenden angiogenesis.
Öz et al. Effects of different doses of curcumin on apoptosis, mitochondrial oxidative stress and calcium ion influx in dbrg glioblastoma cells
Gu et al. Inhibiting myosin light chain kinase retards the growth of mammary and prostate cancer cells
Wang et al. A co-delivery system based on chlorin e6-loaded ROS-sensitive polymeric prodrug with self-amplified drug release to enhance the efficacy of combination therapy for breast tumor cells
CA2541869C (fr) Compositions et procedes servant au ciblage de la destruction vasculaire
US20060100179A1 (en) Compositions and methods for use in targeting vascular destruction
EP1810680A2 (fr) Compositions et procédé d'utilisation pour le ciblage de la destruction vasculaire
AU2004201471B2 (en) Compositions and Methods for Use in Targeting Vascular Destruction
Wang et al. Cdc25A protein phosphatase: a therapeutic target for liver cancer therapies
MXPA01008291A (en) Compositions and methods for use in targeting vascular destruction
JPH10511677A (ja) イノシトール三燐酸の薬剤調製への使用
US20100028417A1 (en) Use of substituted glycerin derivatives for producing a pharmaceutical preparation
Saiko et al. In vitro and in vivo antitumor activity of novel amphiphilic dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20200217